ABSTRACT. The effects of acepromazine-butorphanol (AB), midazolam-butorphanol (MB) and medetomidine (Med) on the induction dose of propofol and their compatibility with propofol were evaluated in client-owned dogs. All premedications induced good to excellent sedation and the induction dose of propofol was considerably reduced. Of the tested premedicants, Med induced the deepest sedation and the most potent dose-sparing effect. Induction of anesthesia was excellent to good in all dogs except for one dog premedica ted with MB. Most dogs premedicated with AB or MB showed temporary apnea. Although other adverse effects such as bradycardia or hypotension may also occur, premedication with MB, AB or Med is a valuable technique for the induction of anesthesia with propofol in dogs in a clinical setting. KEY WORDS: canine, premedication, propofol.
Propofol is an intravenous anesthetic which has highly desirable characteristics such as rapid onset of anesthesia, short duration of action, lack of accumulation upon repeated administration and lack of excitatory effects on induction [1, 16] . Because of these beneficial characteristics, propofol is now accepted as a useful agent in dogs. In veterinary anesthesia, preanesthetic medications such as tranquilizers, sedatives and analgesics are commonly used for the safe and smooth induction of anesthesia. The preanesthetic use of drugs has been shown to have a sparing effect on the induction dose of intravenous anesthetics [4, 10, 11] . Preanesthetic medication has also been reported to modify the cardiovascular effects induced by induction agents. The purpose of this study was to evaluate the effects of acepromazine-butorphanol, midazolam-butorphanol and medetomidine on the dose of propofol needed to induce anesthesia in dogs, and to examine the compatibility of these preanesthetics with propofol in clinical cases.
Eighty client-owned dogs were evaluated in this study. These patients were admitted to the Veterinary Medical Center of the University of Tokyo from April of 2000 to July of 2001 for a variety of surgeries or treatments. Their age, body weight, gender, the type of surgery or treatment and the combination of premedicants used before anesthesia are shown in Table 1 , which also includes the physical status of each animal before anesthesia based on the American Society of Anesthesiologists (ASA) standards [6, 12] . The heart rate (HR) and arterial blood pressure (BP) were monitored non-invasively by a multifunction monitor (Multifunction monitor COLIN BP-58 , Nihon Colin Co. , Tokyo , Japan).
The following drugs were used for preanesthetic medication: intramuscular medetomidine (Med; Domitor, Meijiseika Co., Tokyo , Japan) at a dose of 1,000 µg/m 2 , intravenous midazolam (Dormicum , Yamanouchi Pharmaceutical Co., Tokyo , Japan) and butorphanol (Stadol, Bristol -Myers Squibb Co., Tokyo , Japan) (MB) at doses of 0.1 and 0.2 mg/kg, respectively, and intramuscular acepromazine (Prom Ace, Fort Dodge Laboratories Inc., Iowa , U.S.A.) and butorphanol (AB) at doses of 0.05 and 0.2 mg/ kg, respectively. The doses were determined based on previous research [5, 8] and the drugs were administered 10 to 15 min before the induction of anesthesia. The specific combination of premedicants administered to each dog was chosen by the anesthetists according to the physical status of the animal. Med was selected for patients with ASA status I, MB for ASA I -III, and AB for ASA I -II.
An intravenous catheter was placed in the cephalic vein in all animals before the administration of propofol. Propofol (Rapinovet, Takeda Schering-Plough Animal Health KK, Tokyo, Japan) was aspirated into a syringe at a dose of 7.0 mg/kg, and was then administered intravenously (i.v.) in 60 to 90 sec until the laryngeal reflex disappeared. After intubation, anesthesia was maintained with isoflurane (ISOFUL, Dainippon Pharmaceutical Co., Osaka , Japan) and oxygen. Atropine sulfate (Atropine Sulfate Injection, Tanabe Seiyaku Co., Osaka , Japan) (0.01-0.05 mg/kg, subcutaneously [s.c.], intramuscularly [i.m.] or i.v.) was administered in AB and MB when bradycardia (HR<60) was observed during the procedure.
The effects of premedications on the dose of propofol were examined by comparing them with the dose of propofol reported in the dogs without preanesthetic medication [13] . The difference in the induction dose among the premedicant groups was analyzed by one-way factorial analysis of variance (one-factor ANOVA). Our observations were considered to be statistically significant at P<0.05.
The induction of anesthesia was defined as follows:
excellent, rapid disappearance of laryngeal reflex with smooth induction; good, intubation with depressed laryngeal reflex or mild body movement; fair, if it was necessary to use lidocaine spray (Xylocaine spray, Astra Zeneca KK, Osaka, Japan) to control a laryngeal reflex; and poor, when intubation was difficult and propofol was added and/or mask induction was used to control a laryngeal reflex. Table 2 shows the effects of each preanesthetic medication on the dose of propofol needed for the induction of anesthesia, the quality of the induction as defined above, and adverse effects during and after the induction of anesthesia.
With the exception of one animal, all preanesthetic medications evaluated in this study induced good to excellent sedation before induction of anesthesia and it was possible to handle all the animals safely and easily. The administration of propofol was therefore smooth and the induction dose of propofol was considerably and significantly reduced as compared with the dose of propofol without preanesthetic medication [13] . It was expected that the induction dose of propofol could be reduced depending on the sedative effects induced with each premedication. Of the premedicants used in the present study, Med induced the most profound seda- # Significantly different (P<0.05) from the induction dose of propofol in dogs without preanesthetic medication in our previous study (6.2 ± 0.5 mg/kg) [13] .
tion and also showed the highest reduction in the dose of propofol at 64.5%, an amount similar to that previously reported by Cullen and Reynoldson [2] . Additionally, in a study on healthy young beagles (mean age 11.4 months of old, ASA I) , Kojima et al. [7] reported that premedication with AB had a more potent dose-sparing effect on propofol than MB. In the present study, AB (mean age; 4.8 years old, ASA I-23 dogs , ASA II-7 dogs) and MB (mean age; 7.1 years old, ASA I-21 dogs , ASA II-13 dogs, ASA III-6 dogs) premedication showed almost identical effects on the induction dose of propofol. It is possible that this difference in the results of the two studies can be ascribed to differences in the animals due to selection criteria. In this study, MB was used for older dogs or for dogs considered to be at greater risk, and they were sedated deeply enough to need a lower induction dose of propofol. The quality of induction of anesthesia with propofol was excellent to good in all dogs except for one dog premedicated with MB. In this case, the laryngeal reflex returned during intubation and another dose of propofol was needed and isoflurane anesthesia was maintained after intubation without any apparent problems.
Thirty-three dogs (82.5%) given MB, 27 dogs (90.0%) given AB, and 2 dogs (20%) given Med showed temporary apnea during or immediately after the administration of propofol, but they were managed by assisted or controlled ventilation with 100% oxygen with no complications, and isoflurane anesthesia was smoothly induced. It has been reported that apnea is a major adverse reaction of propofol and that its occurrence depends on the dose and speed of administration [9, 11, 14, 16] . The incidences of apnea in MB and AB patients were almost the same without any premedication in our previous study [13] . The lowest incidence of apnea in Med patients might be related to the resultant lowest induction dose of propofol. The incidence of apnea in young healthy dogs premedicated with AB or MB was also similar to that in unpremedicated dogs even though the induction dose of propofol was reduced moderately [7] . The use of a very low dose of propofol which only induces sedation when used alone might be needed in order to significantly reduce the occurrence of apnea. In a clinical setting, endotracheal intubation and preparation for artificial ventilation are recommended when propofol is used.
Other adverse effects such as bradycardia and hypotension were observed more frequently in this study than in dogs whose anesthesia was induced without premedication [7, 13] . In the present study, bradycardia was observed in 27.5% of the MB group, 40% of the AB group and 70% of the Med group after the administration of premedicants or propofol. It has been reported that changes in heart rate after the administration of MB or AB are usually mild and that bradycardia observed in dogs premedicated with MB and AB may be induced by the additive or supra-additive effects of MB or AB and propofol [8] . It is also well known that medetomidine induces severe bradycardia in dogs [3, 15] . The bradycardia observed in dogs premedicated with Med in the present study was thought to be induced primarily by Med. As the bradycardia observed in this study was reversed by the administration of atropine sulfate in the MB and AB groups, and atipamezole (Antisedan ; Meiji Seika Co., Tokyo , Japan) (100 µg/kg, i.m.) in the Med group, the clinical importance of bradycardia might not be severe. Hypotension and/or tachycardia was observed immediately after the administration of propofol in a few MB and AB dogs. It is possible that MB or AB might enhance the hypotensive effect of propofol, but both adverse effects were mild and were reversed without additional treatment within a few minutes after intubation under inhalation of oxygen.
In conclusion, all premedications evaluated in this study induced good to excellent sedation, smooth the administration of propofol and reduced the induction dose of propofol considerably. Of the premedicants evaluated in this study, Med induced the deepest sedation as well as the most potent dose-sparing effect. The quality of the induction of anesthesia with propofol was excellent to good in all dogs except for one dog premedicated with MB. Most dogs premedicated with AB or MB showed temporary apnea after the induction of anesthesia with propofol. Although other adverse effects such as bradycardia or hypotension may also occur, premedication with MB, AB or Med, these effects are usually mild so that such premedication is a valuable clinical technique for the induction of anesthesia with propofol in dogs.
